Join us for a dynamic online activity exploring the latest insights from a quality improvement initiative focused on improving adherence, persistence, and tolerability of oral therapies for patients with chronic lymphocytic leukemia (CLL). Through expert analysis of patient and provider surveys, the session will assess key barriers impacting patient adherence and present practical strategies for improvement. Engage with leading CLL experts as they examine the latest clinical evidence of novel CLL therapies and share leading approaches to improve multidisciplinary coordinated care to improve patient outcomes. This activity is delivered in partnership with the CLL Society.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/overcoming-barriers-that-inhibit-optimal-adherence-persistence-tolerability
- Start Date: 2025-03-10 05:00:00
- End Date: 2025-03-10 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Beigene USA - Amount: 50000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest